Toxicity of intracameral thymoxamine.
The anterior chamber of adult pigmented rabbits was perfused with 1 ml of either 0.02% or 0.2% thymoxamine hydrochloride in Balanced Salt Solution. Contralateral eyes were either perfused with BSS alone or remained untouched. Measurements were made of corneal thickness and intraocular pressure prior to perfusion and at days 1, 2, 3 and 7 after perfusion. Observations were made of toxic reactions of ocular tissues using slit-lamp biomicroscopy. No effects were noted with 0.02% thymoxamine but 0.2% caused corneal swelling and a reduction in intraocular pressure at day 1. Neither concentration caused any observable toxic responses. Morphologic studies confirm the absence of effects by 0.02% thymoxamine, and that 0.2% causes disturbance of both corneal endothelium and iris-ciliary processes. This data, together with an earlier report on in vitro studies of thymoxamine, allows the conclusion that 0.02% thymoxamine is a safe concentration for use in the anterior chamber and 0.2% yields adverse reactions.[1]References
- Toxicity of intracameral thymoxamine. Green, K., Crosby, V.A., Cheeks, L. Lens and eye toxicity research. (1990) [Pubmed]
Annotations and hyperlinks in this abstract are from individual authors of WikiGenes or automatically generated by the WikiGenes Data Mining Engine. The abstract is from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenesOpen Access LicencePrivacy PolicyTerms of Useapsburg
